- Home
- PHVS vs OMI Comparison
PHVS vs OMI Comparison
Compare PHVS & OMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- OMI
- Stock Information
- Founded
- PHVS 2015
- OMI 1882
- Country
- PHVS Netherlands
- OMI United States
- Employees
- PHVS N/A
- OMI N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- OMI Medical Specialities
- Sector
- PHVS Health Care
- OMI Health Care
- Exchange
- PHVS Nasdaq
- OMI Nasdaq
- Market Cap
- PHVS 1.0B
- OMI 1.0B
- IPO Year
- PHVS 2021
- OMI N/A
- Fundamental
- Price
- PHVS $17.11
- OMI $9.14
- Analyst Decision
- PHVS Strong Buy
- OMI Buy
- Analyst Count
- PHVS 5
- OMI 6
- Target Price
- PHVS $41.60
- OMI $19.58
- AVG Volume (30 Days)
- PHVS 49.2K
- OMI 791.8K
- Earning Date
- PHVS 11-13-2024
- OMI 02-28-2025
- Dividend Yield
- PHVS N/A
- OMI N/A
- EPS Growth
- PHVS N/A
- OMI N/A
- EPS
- PHVS N/A
- OMI N/A
- Revenue
- PHVS N/A
- OMI $10,660,960,000.00
- Revenue This Year
- PHVS N/A
- OMI $4.93
- Revenue Next Year
- PHVS N/A
- OMI $3.75
- P/E Ratio
- PHVS N/A
- OMI N/A
- Revenue Growth
- PHVS N/A
- OMI 4.22
- 52 Week Low
- PHVS $15.21
- OMI $8.76
- 52 Week High
- PHVS $33.00
- OMI $28.35
- Technical
- Relative Strength Index (RSI)
- PHVS 38.75
- OMI 19.37
- Support Level
- PHVS $17.11
- OMI $14.65
- Resistance Level
- PHVS $18.70
- OMI $15.54
- Average True Range (ATR)
- PHVS 1.10
- OMI 0.76
- MACD
- PHVS -0.07
- OMI -0.61
- Stochastic Oscillator
- PHVS 34.65
- OMI 5.53
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.